Product description

Filgrastim is a recombinant human granulocyte colony stimulating factor (rHuG-CSF), produced by recombinant DNA technology using E.coli. It is a 175 amino acid protein, non-glycosylated, and has a molecular weight of approximately 18.8kD. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the addition of an N-terminal methionine necessary for expression in E. coli.brhrbrAppearance Properties: Sterile, clear and colorless liquid for injection in vial

Specifications: 75µg, 100µg, 150µg, 200µg, 300µg and 480µg

Indications:
1. Neutropenia resulting from cancer chemotherapy.
2. Neutrophil decrease after bone marrow transplantation.
3. Neutropenia caused by Myelodysplastic syndrome, neutropenia caused by aplastic anemia; congenital neutropenia, idiopathic neutropenia, Myelodysplastic syndrome with neutropenia and Periodic neutropenia.
4. Patients undergoing peripheral blood progenitor cell collection and therapy.
Read more

Specifications

More products from Xiamen Amoytop Biotech Co. Ltd

View all our products (26)
Filgrastim (rHuG-CSF)

Contact information

Address

Telephone

Website

View all contact information
Customized drug delivery from technology to therapy

Customized drug delivery from technology to therapy

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Your trusted end-to-end CDMO partner

Your trusted end-to-end CDMO partner

Savior Lifetec. Co., the most qualified Carbapenem manufacture in world

Savior Lifetec. Co., the most qualified Carbapenem manufacture...

MARNYS - MARTINEZ NIETO SA. Technology + Innovation + Excellence + Service

MARNYS - MARTINEZ NIETO SA. Technology + Innovation + Excellen...